{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:12:42Z","timestamp":1790845962564,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00508-025-02552-4","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T09:23:47Z","timestamp":1750325027000},"page":"778-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of imatinib in patients with COVID-19: a\u00a0systematic review and meta-analysis"],"prefix":"10.1007","volume":"137","author":[{"given":"Le","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7785-5387","authenticated-orcid":false,"given":"Siyuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"1","key":"2552_CR1","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta\u00a0D, Vanelli\u00a0M. WHO declares COVID-19 a\u00a0pandemic. Acta Biomed. 2020;91(1):157\u201360.","journal-title":"Acta Biomed"},{"issue":"2","key":"2552_CR2","first-page":"E311","volume":"62","author":"Y Alimohamadi","year":"2021","unstructured":"Alimohamadi\u00a0Y, Tola\u00a0HH, Abbasi-Ghahramanloo\u00a0A, Janani\u00a0M, Sepandi\u00a0M. Case fatality rate of COVID-19: a\u00a0systematic review and meta-analysis. J\u00a0Prev Med Hyg. 2021;62(2):E311\u2013E20.","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"2552_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmii.2022.10.003","volume":"56","author":"CC Lai","year":"2023","unstructured":"Lai\u00a0CC, Hsu\u00a0CK, Yen\u00a0MY, Lee\u00a0PI, Ko\u00a0WC, Hsueh\u00a0PR. Long COVID: an inevitable sequela of SARS-coV\u20112 infection. J\u00a0Microbiol Immunol Infect. 2023;56(1):1\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"2552_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","volume":"47","author":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators.","year":"2021","unstructured":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators.. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a\u00a0prospective cohort study. Intensive Care Med. 2021;47(1):60\u201373.","journal-title":"Intensive Care Med"},{"issue":"10300","key":"2552_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(21)00439-6","volume":"398","author":"NJ Meyer","year":"2021","unstructured":"Meyer\u00a0NJ, Gattinoni\u00a0L, Calfee\u00a0CS. Acute respiratory distress syndrome. Lancet. 2021;398(10300):622\u201337.","journal-title":"Lancet"},{"issue":"1","key":"2552_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(23)00493-0","volume":"24","author":"WHK Schilling","year":"2024","unstructured":"Schilling\u00a0WHK, Jittamala\u00a0P, Watson\u00a0JA, Boyd\u00a0S, Luvira\u00a0V, Siripoon\u00a0T, et\u00a0al. PLATCOV collaborative group. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase\u00a02, randomised, controlled, adaptive trial. Lancet Infect Dis. 2024;24(1):36\u201345.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2552_CR7","doi-asserted-by":"publisher","first-page":"e0298772","DOI":"10.1371\/journal.pone.0298772","volume":"19","author":"B Amani","year":"2024","unstructured":"Amani\u00a0B, Amani\u00a0B. Effectiveness and safety of azvudine in COVID-19: a\u00a0systematic review and meta-analysis. PLoS ONE. 2024;19(6):e298772.","journal-title":"PLoS ONE"},{"issue":"6","key":"2552_CR8","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.18632\/aging.202795","volume":"13","author":"S Pei","year":"2021","unstructured":"Pei\u00a0S, Yuan\u00a0X, Zhang\u00a0Z, Yao\u00a0R, Xie\u00a0Y, Shen\u00a0M, et\u00a0al. Convalescent plasma to treat COVID-19: clinical experience and efficacy. Aging. 2021;13(6):7758\u201366.","journal-title":"Aging"},{"issue":"2","key":"2552_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/cells10020206","volume":"10","author":"R Chilamakuri","year":"2021","unstructured":"Chilamakuri\u00a0R, Agarwal\u00a0S. COVID-19: characteristics and therapeutics. Cells. 2021;10(2):206.","journal-title":"Cells"},{"issue":"1","key":"2552_CR10","doi-asserted-by":"publisher","first-page":"21522","DOI":"10.1038\/s41598-021-00726-4","volume":"11","author":"J Malgie","year":"2021","unstructured":"Malgie\u00a0J, Schoones\u00a0JW, Zeegers\u00a0MP, Pijls\u00a0BG. Decreased mortality and increased side effects in COVID-19\u00a0patients treated with IL\u20116 receptor antagonists: systematic review and meta-analysis. Sci Rep. 2021;11(1):21522.","journal-title":"Sci Rep"},{"issue":"9","key":"2552_CR11","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1038\/s41375-021-01266-6","volume":"35","author":"CX Chen","year":"2021","unstructured":"Chen\u00a0CX, Wang\u00a0JJ, Li\u00a0H, Yuan\u00a0LT, Gale\u00a0RP, Liang\u00a0Y. JAK-inhibitors for coronavirus disease-2019 (COVID-19): a\u00a0meta-analysis. Leukemia. 2021;35(9):2616\u201320.","journal-title":"Leukemia"},{"issue":"3","key":"2552_CR12","first-page":"243","volume":"55","author":"IA Wafa","year":"2023","unstructured":"Wafa\u00a0IA, Pratama\u00a0NR, Budi\u00a0DS, Sutanto\u00a0H, Rosyid\u00a0AN, Wungu\u00a0CDK. The efficacy and safety of Monoclonal antibody treatments against COVID-19: a\u00a0systematic review and meta-analysis of randomized clinical trials. Acta Med Indones. 2023;55(3):243\u201354.","journal-title":"Acta Med Indones"},{"issue":"6","key":"2552_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S2213-2600(17)30188-1","volume":"5","author":"MA Matthay","year":"2017","unstructured":"Matthay\u00a0MA, McAuley\u00a0DF, Ware\u00a0LB. Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med. 2017;5(6):524\u201334.","journal-title":"Lancet Respir Med"},{"issue":"23","key":"2552_CR14","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1161\/CIRCULATIONAHA.112.134304","volume":"126","author":"J Aman","year":"2012","unstructured":"Aman\u00a0J, van Bezu\u00a0J, Damanafshan\u00a0A, Huveneers\u00a0S, Eringa\u00a0EC, Vogel\u00a0SM, et\u00a0al. Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation. 2012;126(23):2728\u201338.","journal-title":"Circulation"},{"issue":"12","key":"2552_CR15","doi-asserted-by":"publisher","first-page":"e85231","DOI":"10.1371\/journal.pone.0085231","volume":"8","author":"EM Chislock","year":"2013","unstructured":"Chislock\u00a0EM, Pendergast\u00a0AM. Abl family kinases regulate endothelial barrier function in vitro and in mice. Plos One. 2013;8(12):e85231.","journal-title":"Plos One"},{"issue":"11","key":"2552_CR16","doi-asserted-by":"publisher","first-page":"L1294","DOI":"10.1152\/ajplung.00031.2015","volume":"309","author":"AN Rizzo","year":"2015","unstructured":"Rizzo\u00a0AN, Sammani\u00a0S, Esquinca\u00a0AE, Jacobson\u00a0JR, Garcia\u00a0JG, Letsiou\u00a0E, Dudek\u00a0SM. Imatinib attenuates inflammation and vascular leak in a\u00a0clinically relevant two-hit model of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2015;309(11):L1294\u2013304.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"2552_CR17","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1186\/cc12786","volume":"17","author":"IK Kim","year":"2013","unstructured":"Kim\u00a0IK, Rhee\u00a0CK, Yeo\u00a0CD, Kang\u00a0HH, Lee\u00a0DG, Lee\u00a0SH, Kim\u00a0JW. Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery. Crit Care. 2013;17(3):R114.","journal-title":"Crit Care"},{"issue":"5","key":"2552_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/ATVBAHA.115.305085","volume":"35","author":"AN Rizzo","year":"2015","unstructured":"Rizzo\u00a0AN, Aman\u00a0J, van Nieuw Amerongen\u00a0GP, Dudek\u00a0SM. Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome. Arterioscler Thromb Vasc Biol. 2015;35(5):1071\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2552_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10456-021-09781-x","volume":"24","author":"J Amado-Azevedo","year":"2021","unstructured":"Amado-Azevedo\u00a0J, van Stalborch\u00a0AD, Valent\u00a0ET, Nawaz\u00a0K, van Bezu\u00a0J, Eringa\u00a0EC, et\u00a0al. Depletion of Arg\/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation. Angiogenesis. 2021;24(3):677\u201393.","journal-title":"Angiogenesis"},{"key":"2552_CR20","first-page":"128","volume":"106677","author":"AN Rizzo","year":"2020","unstructured":"Rizzo\u00a0AN, Belvitch\u00a0P, Demeritte\u00a0R, Garcia\u00a0JGN, Letsiou\u00a0E, Dudek\u00a0SM. Arg mediates LPS-induced disruption of the pulmonary endothelial barrier. Vasc Pharmacol. 2020;106677:128\u20139.","journal-title":"Vasc Pharmacol"},{"key":"2552_CR21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page\u00a0MJ, McKenzie\u00a0JE, Bossuyt\u00a0PM, Boutron\u00a0I, Hoffmann\u00a0TC, Mulrow\u00a0CD, et\u00a0al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"1","key":"2552_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad\u00a0AR, Moore\u00a0RA, Carroll\u00a0D, Jenkinson\u00a0C, Reynolds\u00a0DJ, Gavaghan\u00a0DJ, McQuay\u00a0HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"key":"2552_CR23","volume-title":"Cochrane handbook for systematic reviews of interventions version\u00a06.4","author":"JPT Higgins","year":"2023","unstructured":"Higgins\u00a0JPT, Savovi\u0107\u00a0J, Page\u00a0MJ, Elbers\u00a0RG, Sterne\u00a0JAC. Chapter 8: assessing risk of bias in a\u00a0randomized trial. In: Higgins\u00a0JPT, Thomas\u00a0J, Chandler\u00a0J, Cumpston\u00a0M, Li\u00a0T, Page\u00a0MJ, Welch\u00a0VA, editors. Cochrane handbook for systematic reviews of interventions version\u00a06.4 Cochrane; 2023. www.training.cochrane.org\/handbook."},{"key":"2552_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan\u00a0X, Wang\u00a0W, Liu\u00a0J, Tong\u00a0T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"2552_CR25","doi-asserted-by":"publisher","first-page":"e28495","DOI":"10.1002\/jmv.28495","volume":"95","author":"A Morales-Ortega","year":"2023","unstructured":"Morales-Ortega\u00a0A, Farf\u00e1n-Sedano\u00a0AI, San Mart\u00edn-L\u00f3pez\u00a0JV, Escrib\u00e1-B\u00e1rcena\u00a0A, Jaenes-Barrios\u00a0B, Madro\u00f1al-Cerezo\u00a0E, COVINIB Study Group investigators, et\u00a0al. Baricitinib or imatinib in hospitalized COVID-19\u00a0patients: results from COVINIB, an exploratory randomized clinical trial. J\u00a0Med Virol. 2023;95(2):e28495.","journal-title":"J Med Virol"},{"issue":"1","key":"2552_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13054-023-04516-4","volume":"27","author":"LN Atmowihardjo","year":"2023","unstructured":"Atmowihardjo\u00a0LN, Schippers\u00a0JR, Duijvelaar\u00a0E, Bartelink\u00a0IH, Bet\u00a0PM, Swart\u00a0NEL, et\u00a0al. Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a\u00a0randomized, double-blind, placebo-controlled clinical trial. Crit Care. 2023;27(1):226.","journal-title":"Crit Care"},{"issue":"3","key":"2552_CR27","doi-asserted-by":"publisher","first-page":"106217","DOI":"10.1016\/j.jinf.2024.106217","volume":"89","author":"ALE Halme","year":"2024","unstructured":"Halme\u00a0ALE, Laakkonen\u00a0S, Rutanen\u00a0J, Nevalainen\u00a0OPO, Sinisalo\u00a0M, Horstia\u00a0S, et\u00a0al. Short- and long-term effects of imatinib in hospitalized COVID-19\u00a0patients: a\u00a0randomized trial. J\u00a0Infect. 2024;89(3):106217.","journal-title":"J Infect"},{"issue":"9","key":"2552_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S2213-2600(21)00237-X","volume":"9","author":"J Aman","year":"2021","unstructured":"Aman\u00a0J, Duijvelaar\u00a0E, Botros\u00a0L, Kianzad\u00a0A, Schippers\u00a0JR, Smeele\u00a0PJ, et\u00a0al. Imatinib in patients with severe COVID-19: a\u00a0randomised, double-blind, placebo-controlled, clinical trial. Lancet Respir Med. 2021;9(9):957\u201368.","journal-title":"Lancet Respir Med"},{"key":"2552_CR29","doi-asserted-by":"crossref","unstructured":"Chagas JPS, de Oliveira JR, Brand\u00e3o VA, Bellucio APB, Dutra JVA, Dutra JR, et\u00a0al. Evaluating imatinib in severe COVID-19: a\u00a0systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2024;.","DOI":"10.1093\/trstmh\/trae095"},{"issue":"7","key":"2552_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1787","volume":"14","author":"EJ Su","year":"2008","unstructured":"Su\u00a0EJ, Fredriksson\u00a0L, Geyer\u00a0M, Folestad\u00a0E, Cale\u00a0J, Andrae\u00a0J, et\u00a0al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med. 2008;14(7):731\u20137.","journal-title":"Nat Med"},{"issue":"3","key":"2552_CR31","doi-asserted-by":"publisher","first-page":"L259","DOI":"10.1152\/ajplung.00323.2014","volume":"308","author":"E Letsiou","year":"2015","unstructured":"Letsiou\u00a0E, Rizzo\u00a0AN, Sammani\u00a0S, Naureckas\u00a0P, Jacobson\u00a0JR, Garcia\u00a0JG, et\u00a0al. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2015;308(3):L259\u201369.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"2552_CR32","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1172\/JCI124884","volume":"129","author":"V Langer","year":"2019","unstructured":"Langer\u00a0V, Vivi\u00a0E, Regensburger\u00a0D, Winkler\u00a0TH, Waldner\u00a0MJ, Rath\u00a0T, et\u00a0al. IFN\u2011\u03b3 drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. J\u00a0Clin Invest. 2019;129(11):4691\u20134607.","journal-title":"J Clin Invest"},{"issue":"4","key":"2552_CR33","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/S2213-2600(22)00052-2","volume":"10","author":"E Duijvelaar","year":"2022","unstructured":"Duijvelaar\u00a0E, Schippers\u00a0JR, Smeele\u00a0PJ, de Raaf\u00a0MA, Vanhove\u00a0ALEM, Blok\u00a0SG, et\u00a0al. Long-term clinical outcomes of COVID-19\u00a0patients treated with imatinib. Lancet Respir Med. 2022;10(4):e34\u20135.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2552_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13054-024-04819-0","volume":"28","author":"N Alipanah-Lechner","year":"2024","unstructured":"Alipanah-Lechner\u00a0N, Hurst-Hopf\u00a0J, Delucchi\u00a0K, Swigart\u00a0L, Willmore\u00a0A, LaCombe\u00a0B, I\u2011SPY COVID Consortium, et\u00a0al. Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a\u00a0secondary analysis of a\u00a0randomized controlled trial. Crit Care. 2024;28(1):56.","journal-title":"Crit Care"},{"issue":"6","key":"2552_CR35","doi-asserted-by":"publisher","first-page":"2200780","DOI":"10.1183\/13993003.00780-2022","volume":"60","author":"J de Brabander","year":"2022","unstructured":"de Brabander\u00a0J, Duijvelaar\u00a0E, Schippers\u00a0JR, Smeele\u00a0PJ, Peters-Sengers\u00a0H, Duitman\u00a0JW, CounterCOVID Study Group, et\u00a0al. Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19\u00a0patients. Eur Respir\u00a0J. 2022;60(6):2200780.","journal-title":"Eur Respir J"},{"issue":"5","key":"2552_CR36","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/cbin.11992","volume":"47","author":"H Alavifard","year":"2023","unstructured":"Alavifard\u00a0H, Mazhari\u00a0S, Meyfour\u00a0A, Tokhanbigli\u00a0S, Ghavami\u00a0S, Zali\u00a0MR, et\u00a0al. Imatinib suppresses activation of hepatic stellate cells by targeting STAT3\/IL\u20116 pathway through miR-124. Cell Biol Int. 2023;47(5):969\u201380.","journal-title":"Cell Biol Int"},{"key":"2552_CR37","doi-asserted-by":"crossref","unstructured":"Zhang J, Hao Y, Ou W, Ming F, Liang G, Qian Y, et\u00a0al. Serum interleukin\u20116 is an indicator for severity in 901 patients with SARS-CoV\u20112 infection: a\u00a0cohort study. J\u00a0Transl Med. 2020;18(1).","DOI":"10.1186\/s12967-020-02571-x"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02552-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-025-02552-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-025-02552-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:36:49Z","timestamp":1765964209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-025-02552-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":37,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1007\/s00508-025-02552-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.\u00a0Li,C.\u00a0Zhao and S.\u00a0Hou declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}